Veracyte, Inc. (VCYT)
NASDAQ·Healthcare·Biotechnology
$33.41
-1.30%
Mkt Cap $2.66B
Analyst Ratings
Buy
7
Hold
2
Sell
3
Price Target (11 analysts)
$44.50
Range $37.00 – $50.00
Implied Upside
+33.2%
Consensus $44.50 vs current $33.41
NASDAQ·Healthcare·Biotechnology
$33.41
-1.30%
Mkt Cap $2.66B
Buy
7
Hold
2
Sell
3
Price Target (11 analysts)
$44.50
Range $37.00 – $50.00
+33.2%
Consensus $44.50 vs current $33.41